Dopant-induced electron localization drives CO 2 reduction to C 2 hydrocarbons
read more
Citations
Amorphous NxC Coating Promotes Electrochemical CO2 Deep Reduction to Hydrocarbons over Ag Nanocatalysts
Selective C2 electrochemical synthesis from methane on modified alumina supporting single atom catalysts
p-d Orbital Hybridization Induced by p-Block Metal-Doped Cu Promotes the Formation of C2+ Products in Ampere-Level CO2 Electroreduction.
Electrocatalytic Carbon Dioxide Reduction to Ethylene over Copper-based Catalytic Systems.
Hollow Copper Nanocubes Promoting CO2 Electroreduction to Multicarbon Products
References
Efficiency of ab-initio total energy calculations for metals and semiconductors using a plane-wave basis set
Ab initio molecular dynamics for liquid metals.
Electrochemical Methods: Fundamentals and Applications
Environmental, economic, and energetic costs and benefits of biodiesel and ethanol biofuels
Supporting Online Material for: Ethanol Can Contribute To Energy and Environmental Goals
Related Papers (5)
CO2 electroreduction to ethylene via hydroxide-mediated copper catalysis at an abrupt interface
Progress and Perspectives of Electrochemical CO2 Reduction on Copper in Aqueous Electrolyte
Frequently Asked Questions (11)
Q2. What is the comorbidity of the rasch type?
The transition of pure mood, anxiety and substance use disorders into 520 comorbid conditions in a longitudinal population-based study.
Q3. What was the goodness of fit for all multivariate models?
The goodness of fit for all multivariate models was 226evaluated with the -2 Log Likelihood (-2LL) method by comparing the fitted fixed-effects 227models to the model with no predictors (null model).
Q4. What are the limitations of this study?
because of a lack of power, multivariate 332analyses were not performed on course types, making it difficult to clarify the strongest 333prognostic factors of an unfavorable course type.
Q5. How long after baseline did the study take?
Follow-up assessments by means of a face-to-face 120 interview were performed two-years,13 and six-years after baseline using the same 121measurement instruments as at baseline.
Q6. What was the recent study of the Netherlands Study of Depression in Older persons?
In their previous 75two-year follow-up study of the Netherlands Study of Depression in Older persons (NESDO), 76we found that nearly 50% of the clinically depressed patients still had a depression 77 diagnosis, and 61% had a chronic course of depressive symptoms.
Q7. how many patients had a full remission at six years?
251252253254Page 12 of 3213Prognosis of late-life depression 255Among the total of 378 depressed patients at baseline, 177 (46.8%) were loss to follow-up, 25660 (15.9%) had a recurrent or chronic depression, 93 (24.6%) had a partial remission and 257only 48 (12.7%) had a full remission at six-year follow-up.
Q8. How did Beekman et al. (2002) study the course of late-life?
9–14 Beekman et al. (2002) studied the six-year 72course of community-dwelling older adults with late-life depression, using both diagnostic 73Page 3 of 324interviews and self-reports, and found that 32% had a severe chronic course and 44% an 74 unfavorable but fluctuating course, whereas only 23% showed remission.
Q9. What is the important conclusion to draw from this study?
283Page 14 of 3215Discussion (Words: 1124) 284The most important conclusion to be drawn from this study among depressed older patients 285is that the long-term prognosis for this group is poor in terms of mortality and course of 286depression.
Q10. How did Stek et al. (2002) determine the prognosis of major?
5 Stek et al. (2002) 306examined the long-term prognosis of major depression in hospitalized older patients six to 307Page 15 of 3216eight year after clinical treatment and found that 40% had died, while among the survivors 308 33% had no residual symptoms or relapses,11 which approximately corresponds to their 309finding that among survivors 24% reached full remission.
Q11. What were the health and lifestyle factors included in the study?
The following health and 181Page 8 of 329lifestyle factors were included: chronic physical diseases were self-reported and assessed by 182 the LASA Questionnaire (LAPAQ),37 functional limitations were assessed by the WHO-183 Disability Assessment Scale II (WHODAS 2.0),38 metabolic syndrome was assessed by the 184 original ATP-III criteria,39 chronic pain was assessed by the Chronic Graded Pain Scale 185 (CPGS),40 body-mass-index was measured by weight (kg)/squared height (m2), physical 186activity was assessed by the International Physical Activities Questionnaire (IPAQ) and 187 dichotomized (low versus moderate/high),41 smoking was assessed by asking current 188smoking behavior (y/n), and alcohol use was assessed by Alcohol Use Disorders 189 Identification (AUDIT).